Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.
Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S.
Medical Device Network on MSN
Sonire Therapeutics raises $18m for tumour ablation platform advancement
Sonire said the Series A funds will allow it to complete the randomised control trial of its high-intensity focused ...
NeuroOne developed OneRF to treat epilepsy and recently took first steps to expand its use to trigeminal neuralgia.
Johnson & Johnson (J&J) has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety ...
Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its ...
The Society of Interventional Radiology (SIR) announced that the CAPTAIN randomized clinical trial found that men with ...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.
Catheter ablation tools A retrospective study revealed no significant difference in 36-month progression-free survival and renal function outcomes in patients with small renal masses. Microwave ...
Cystoscopy with diathermy or resection is the current standard treatment for patients with non-muscle-invasive bladder cancer (NMIBC). However, it is associated with a high risk of recurrence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results